Menu
Décideurs

De Gaulle Fleurance recognized in the Décideurs – Leaders League 2025 ranking, category: Healthcare, Pharma, and Biotechnology

Awards 5 September 2025
Health law and life sciences Life sciences, health

De Gaulle Fleurance is proud to be recognized in the Décideurs – Leaders League 2025 ranking for its expertise in Healthcare, Pharma, and Biotechnology, reflecting the commitment and excellence of our experts in supporting our clients in this area.

Regulatory law - Essential

Frédéric
Destal
Partner
Cécile
Théard-Jallu
Partner

E-health - Essential

Cécile
Théard-Jallu
Partner

Patents / Pharma, biotech, and life sciences litigation - Excellent

Louis
de Gaulle
Partner
Julien
Horn
Partner
Francine
Le Péchon-Joubert
Partner

Licensing, co-development, and R&D agreements - Excellent

Francine
Le Péchon-Joubert
Partner
Cécile
Théard-Jallu
Partner

Healthcare criminal law - Strong reputation

Albane
Lancrenon
Partner

Capital operations, joint ventures, and corporate - Strong reputation

Jean-Christophe
Amy
Partner
François
Couhadon
Partner

Venture capital operations - Strong reputation

Jean-Christophe
Amy
Partner
Henri-Nicolas
Fleurance
Partner

Distribution law - Strong reputation

Cécile
Théard-Jallu
Partner
Thierry
Titone
Partner
Would you like to be kept up to date with the latest news on this topic?
Sign up to receive e-mails of new articles, events, analysis... on the subjects most relevant to you.
Create your customized watch

Receive news on the topics
that matter to you

Latest news

More news
Articles 12 February 2026
Chambers Global Guide 2026: De Gaulle Fleurance Recognised Once Again
Caisse d'Epargne CEPAC
Deals 9 February 2026
CAISSE D’EPARGNE CEPAC, advised by De Gaulle Fleurance, is providing €8.7 million in bank financing for “Notre Énergie Vitrolles”.
Deals 4 February 2026
Financing of secondary LBO on Asia Group: De Gaulle Fleurance advised the pool of banks on the implementation of the bank debt
Deals 2 February 2026
De Gaulle Fleurance advises SunWave on €20 million green bank financing backed by self-consumption models